shutterstock_1755486332_anton_medvedev
Anton_Medvedev / Shutterstock.com
10 August 2021EuropeSophie Topham

UK experimental use exemptions: Part 4—the SPC manufacturing and stockpiling waiver

In the final article of a four-part series, Sophie Topham of Marks & Clerk discusses the supplementary protection certificate manufacturing waiver

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
30 April 2026   Data from Questel indicates a radical restructuring of IP professionals’ duties, as adoption and demand rates continue to rise.
Europe
30 April 2026   The company’s rivals convinced an EPO appeals board to revoke a patent that had been used in litigation against them over Comirnaty.
Europe
24 April 2026   An opinion has put pressure on the CJEU to clarify a long-running grey area that could change the game for how drug makers secure supplementary protection certificates across Europe.